RxDoctor Payments Data

Caroline Steinman, DO

Family Medicine · Vincennes, INNPI 1750643573

Payments from drug & device makers

$506in general payments, 2019–2025

Across 36 payments — averaging $14.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$220
  • Lilly USA, LLC$47
  • Johnson & Johnson$40
  • Amgen$32
  • E.r. Squibb & Sons, L.L.C.$27
  • Pfizer$25
  • plus $115 from 8 others

What the payments were for

  • Food & beverage$506100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$506 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$5,481
Medicare patients
34
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide175$192,630
MounjaroTirzepatide132$152,824
EliquisApixaban115$121,158
TrulicityDulaglutide67$75,598
Trelegy ElliptaFluticasone/Umeclidin/Vilanter94$68,504
JanuviaSitagliptin Phosphate54$56,599
RexultiBrexpiprazole31$55,821
FarxigaDapagliflozin Propanediol61$44,681
XareltoRivaroxaban46$40,711
Tresiba Flextouch U-100Insulin Degludec69$36,428
Emgality PenGalcanezumab-Gnlm46$33,647
JardianceEmpagliflozin34$30,673
QuliptaAtogepant21$24,717
RybelsusSemaglutide22$21,503
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr44$21,453

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$47$228,422199 claims
Novo NordiskOzempic, Rybelsus$12$214,133197 claims
PfizerEliquis$25$121,158115 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$24$103,218172 claims
MerckJanuvia, Belsomra$13$63,65770 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$14$50,43875 claims
Johnson & JohnsonXarelto$40$40,71146 claims
AbbVieQulipta, Linzess$220$33,69436 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Vincennes

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →